|
|
Latest Story |
Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED) |
PR Newswire |
-- On an Intent-to-Treat Analysis, Co-Primary Symptom Endpoint Met, Statistical Significance (P<0.025) -- Multiple Secondary Symptom Endpoints Met, Statistical Significance (P<0.025) -- On an Intent-to-Treat Analysis, Co-Primary Sign Endpoint and Secondary Sign Endpoints Not Met |
Full Story → |
Headline News |
Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update |
7:30a ET February 15 '24 PR Newswire |
Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024 |
7:30a ET February 9 '24 PR Newswire |
Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED) |
7:30a ET February 5 '24 PR Newswire |
More News → |
|
Today, 11:29a ET Thursday March 28 '24. Markets Open. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Previous data from yesterday, March 27 '24. |